Project Grant R01CA284082
Award Date
9/6/24
Completion Date
8/31/28
Dollars Obligated
$753K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21201, USA
Similar Awards
The National Cancer Institute (NCI) awarded a $794,530 Project Grant under the CFDA 93.394 Cancer Detection and Diagnosis Research program to the Sloan-Kettering Institute for Cancer Research. The 5-year grant, starting on September 1, 2024, will fund a randomized controlled trial to evaluate the efficacy of time-restricted eating in reducing weight and improving cardiometabolic risk factors among 300 radiation-exposed survivors of childhood cancer with overweight/obesity. The study will...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides funding of $638,326 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to adapt and evaluate a cognitive behavioral therapy intervention for reducing fatigue among women with metastatic breast cancer treated with a CDK4/6 inhibitor. The key products and services to be delivered under this grant include: 1) Adapting an evidence-based cognitive behavioral therapy...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $772,246 to The Salk Institute for Biological Studies to conduct a clinical study on the effects of time-restricted eating (TRE) and TRE with a low-glycemic snack (TRE-LGS) as dietary interventions to improve the health of overweight and obese night shift workers. The study will...
This Project Grant award from the National Cancer Institute (CFDA 93.398 Cancer Research Manpower) to Northwestern University is intended to examine physical activity promotion intervention outcomes, barriers, and facilitators in breast cancer survivors with fatigue. The $130,001 award will fund a study that includes secondary data analyses from a prior mobile health physical activity intervention, as well as a needs assessment to understand multi-level stakeholder perspectives on barriers and...
This federal Project Grant award, in the amount of $594,734, was provided by the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) to investigate the effects of a telehealth exercise program for rural cancer survivors experiencing cancer-related fatigue. The primary objectives are to evaluate the efficacy of the "BFITBWell Telehealth Program" for improving cancer-related fatigue in rural breast and prostate cancer survivors, and to examine the...
This $163,319 Project Grant award from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports research at the University of California, Irvine to investigate how disruption of the circadian clock influences the immune landscape and promotes colorectal cancer initiation and progression. The project aims to determine how clock disruption alters in vivo immune responses, specifically activating myeloid-derived suppressor cells and suppressing cytotoxic CD8+ T cells,...
This $767,324 Cooperative Agreement award from the National Cancer Institute (NCI) under the Cancer Biology Research federal grant program (CFDA 93.396) aims to determine the mechanisms by which caloric restriction boosts anti-tumor immunity mediated by CD8 T cells. Specifically, the research will investigate how dietary fats influence anti-tumor T cell responses in the context of caloric restriction, how caloric restriction differentially controls T cell metabolism in the tumor...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will provide $713,235 to the H. Lee Moffitt Cancer Center and Research Institute to conduct the first fully powered randomized controlled trial evaluating the efficacy of the MIND diet in improving cancer-related cognitive impairment (CRCI) among breast cancer survivors. The study will enroll 200 breast cancer survivors who have completed treatment within the past 3 years and are...
The National Cancer Institute (NCI) awarded a $406,217 Project Grant (CFDA 93.395 - Cancer Treatment Research) to the University of Texas Health Science Center at Houston (UTHealth) to investigate the circadian regulation of astrocytic adenosine kinase (ADK) in the irradiated and cancer brain. The research aims to determine the impact of the circadian clock proteins BMAL1 and CLOCK on ADK expression and sleep/wake regulation following cranial radiotherapy (CRT) for brain cancers. The project...
This Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research program) provides funding to Northwestern University to study the underlying mechanisms by which certain types of cancers induce systemic changes in the vasculature and lymphatic system that contribute to the development of cancer cachexia. The $502,563 award, which runs from July 2024 to June 2029, supports a two-pronged research approach. The first focus is to further elucidate the molecular...